Oruka Therapeutics, Inc. (ORKA)

NASDAQ: ORKA · Real-Time Price · USD

105.35

+0.36 (0.34%)

At close: Nov 13, 2026, 4:00 PM EST

106.15

+0.80 (0.76%)

After-hours: Nov 13, 2026, 7:30 PM EST

Oruka Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Income	-183.11	-122.05	-95.26
Net Income	-130.37	-84.31	-70.95
Earnings Per Share	-2.13	-1.85	-4.23
EPS Growth	-	-	-

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	1,207	479.58	393.72
Total Debt	2.93	1.93	0.97
Net Cash (Debt)	1,204	477.65	392.75
Net Cash Growth	141.21%	21.62%	-
Net Cash Per Share	19.70	10.47	23.39

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-123.64	-88.21	-63.09
Capital Expenditures	-0.22	-0.21	-0.21
Free Cash Flow	-123.86	-88.42	-63.3
Free Cash Flow Growth	-	-	-

Selected indicators aren't available for this stock.